All News #Library
Quality
Wockhardt, Withdrawal of Approval of 28 Abbreviated New Drug Applications
15 Feb 2020 //
FEDERALREGISTER
28 Unique Data Integrity Deficiencies That Aren’t Really Unique
02 Jun 2017 //
FDAZILLA
NPPA`s drug overcharging penalty at a record high
11 Mar 2017 //
BUSINESS STANDARD
Wockhardt falls over 5% as US unit gets FDA warning letter
01 Mar 2017 //
BUSINESS-STANDARD
Top pharma cos overcharging, NPPA lists 634 drugs for breaching price cap
27 Feb 2017 //
BUSINESS STANDARD
Mezzion sues Dr. Reddy`s for Fraud
25 Jan 2017 //
FIERCE PHARMA
Concerns at Wockhardt, Hospira Plants Factor into CRL issued to Cempra
04 Jan 2017 //
FIERCE PHARMA
Wockhardt Shares Fall After FDA Warning Letter on U.K. Factory
23 Nov 2016 //
BLOOMBERG
Interpharm gets FDA warning letter for Czech plant
27 Oct 2016 //
FIERCE PHARMA
Top Class I drug recallers
17 Jun 2015 //
FIERCE PHARMA MANUFACTURING
Two drugs manufactured by Wockhardt recalled in the US
07 Jun 2015 //
THE ECONOMIC TIMES
NPPA issues final warning to 19 major cos for failing to register with IPDMS
04 Jun 2015 //
PHARMABIZ
Poor compliance an issue with Indian drug firms: Deloitte Survey
04 Jun 2015 //
BUSINESS TODAY IN
India`s Wockhardt To Recall Some Drugs Made In India After U.S. FDA Concerns
28 Apr 2015 //
REUTERS
Facilities of Aarti Drugs on USFDA Import Alert List
25 Mar 2015 //
FIERCE PHARMA MANUFACTURING

Market Place
Sourcing Support